Showing 1 - 10 of 8,417
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10009571572
Persistent link: https://www.econbiz.de/10009562304
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets that control adverse selection and assure adequate access and coverage. The focus of this paper is on the ability of consumers to evaluate and optimize...
Persistent link: https://www.econbiz.de/10009666978
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10013104980
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10012460495
Persistent link: https://www.econbiz.de/10011724078
Dieser Band der Bad Orber Gespräche 2016 enthält die erweiterten Referate eines interdisziplinären Workshops zum Thema "Neuerungen im Krankenhaus- und Arzneimittelbereich zwischen Bedarf und Finanzierung". Vertreter des Deutschen Bundestages, des Gemeinsamen Bundesausschusses, des...
Persistent link: https://www.econbiz.de/10011929966
Persistent link: https://www.econbiz.de/10000563687
Persistent link: https://www.econbiz.de/10011347343
Persistent link: https://www.econbiz.de/10002179264